
Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes. The Iterative Health Site Network is a premier network of 100+ clinical research sites across the US and Europe, accelerating the path to market for novel therapies. By combining deep expertise in clinical trials with cutting-edge AI, we empower research teams and study sponsors to expand and expedite access to novel therapeutics for patients in need.
About the Role
As the Manager, Growth, you will play a critical operational role at the center of Iterative Health's two core growth engines in Cardiology: expanding our sponsor portfolio and scaling our site network. This is a high-visibility, high-impact role for a sharp operator who thrives on process ownership, cross-functional coordination, and getting things done in a fast-moving environment. You will own the internal mechanics of business development — keeping the pipeline moving, deals progressing, and sponsors well-served — while simultaneously driving the operational build-out of new clinical research sites from contract execution through first study activation. The ideal candidate brings a strategic and operational mindset, is energized by variety, and is able to manage multiple workstreams with rigor and speed.
Responsibilities
Sponsor Growth: Business Development & Alliance Management Support
Site Network Growth: De Novo Site Builds
Required Qualifications
Preferred Qualifications
New York pay range $110,000—$140,000 USD
At Iterative Health, we’re actively working towards creating an environment that is representative of the diversity of patients our technology serves. We are focused on building an equitable and inclusive culture, and by extension, hiring process. If you require any accommodations to make the application process or interviewing experience more accessible to you, please contact CandidateAccommodations@iterative.health.

Iterative Health is a healthcare services company accelerating the advancement of clinical research to improve patient outcomes. Our Site Network includes over 80 premier clinical research sites across the U.S. and Europe, focused on bringing novel therapies in gastroenterology and hepatology to market faster. We partner closely with sites to streamline trial execution and support sustainable growth. With deep expertise in clinical operations and study execution, we help research teams and sponsors expand access to promising new treatments for the patients who need them most.